Effectiveness of therapeutic communities: A systematic review

European Addiction Research

Volumn 18, Issue 1, 2011, Pages 1-11

  Malivert, Marion ^a,b   Fatséas, Mélina ^a,b   Denis, Cécile ^a,b   Langlois, Emmanuel ^c   Auriacombe, Marc ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c Centre mile Durkheim   (France)

Author keywords

Adults; Substance related disorders; Systematic review; Therapeutic community

Indexed keywords

COMORBIDITY; DRUG USE; DRUG WITHDRAWAL; FOLLOW UP; HEALTH PROGRAM; HUMAN; MEDLINE; MENTAL DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; THERAPEUTIC COMMUNITY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROGRAM EVALUATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; THERAPEUTIC COMMUNITY;

EID: 80053926080     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000331007     Document Type: Review

References (41)

1. Bourgeois M, Delile JM, Rager P, Peyre F: Therapeutic communities for drug addicts. Assessment and evaluation of care. Ann Med Psychol (Paris) 1987; 145: 699-704.
2. Carreau-Rizzeto M: Comorbidité et communauté thérapeutique. Ann Med Psychol (Paris) 2003; 161: 290-295.
3. Lert F, Fombonne E: La toxicomanie: Vers une évaluation de ses traitements. Paris, La documentation française, 1989.
4. Broekaert E: What future for the therapeutic community in the field of addiction? A view from Europe. Addiction 2006; 101: 1677-1678. (Pubitemid 44899684)
5. De Leon G: Alcohol use among drug abusers: Treatment outcome in a therapeutic community. Alcohol Clin Exp Res 1987; 11: 430-436. (Pubitemid 17161090)
6. De Leon G, Staines GL, Perlis TE, Sacks S, McKendrick K, Hilton R, Brady R: Therapeutic community methods in methadone maintenance (passages): An open clinical trial. Drug Alcohol Depend 1995; 37: 45-57.
7. Etheridge RM, Craddock SG, Dunteman GH, Hubbard RL: Treatment services in two national studies of community-based drug abuse treatment programs. J Subst Abuse 1995; 7: 9-26.
8. Fernandez-Hermida JR, Secades-Villa R, Fernandez-Ludena JJ, Marina-Gonzalez PA: Effectiveness of a therapeutic community treatment in Spain: A long-term follow-up study. Eur Addict Res 2002; 8: 22-29. (Pubitemid 34701981)
9. Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J: Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav 2004; 29: 1875-1882. (Pubitemid 39458002)
10. Moos RH, Finney JW, Moos BS: Inpatient substance abuse care and the outcome of subsequent community residential and outpatient care. Addiction 2000; 95: 833-846. (Pubitemid 30418975)
11. Moos RH, Moos BS, Andrassy JM: Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv 1999; 50: 1577-1583.
12. Nemes S, Wish ED, Messina N: Comparing the impact of standard and abbreviated treatment in a therapeutic community. Findings from the District of Columbia treatment initiative experiment. J Subst Abuse Treat 1999; 17: 339-347. (Pubitemid 29528370)
13. Ravndal E: Research in the concept-based therapeutic community - its importance to European treatment research in the drug field. Int J Soc Welfare 2003; 12: 229-238. (Pubitemid 37458238)
14. Smith LA, Gates S, Foxcroft D: Therapeutic communities for substance related disorder. Cochrane Database Syst Rev 2006; CD005338.
15. Orlando M, Wenzel SL, Ebener P, Edwards MC, Mandell W, Becker K: The dimensions of change in therapeutic community treatment instrument. Psychol Assess 2006; 18: 118-122. (Pubitemid 43824270)
16. Egelko S, Galanter M: Impact of social anxiety in a 'therapeutic community' - oriented cocaine treatment clinic. Am J Addict 1998; 7: 136-141. (Pubitemid 28228686)
17. Chan KS, Wenzel S, Orlando M, Montagnet C, Mandell W, Becker K, Ebener P: How important are client characteristics to understanding treatment process in the therapeutic community? Am J Drug Alcohol Abuse 2004; 30: 871-891. (Pubitemid 39578308)
18. Dekel R, Benbenishty R, Amram Y: Therapeutic communities for drug addicts: Prediction of long-term outcomes. Addict Behav 2004; 29: 1833-1837. (Pubitemid 39457995)
19. Toumbourou JW, Hamilton M, Fallon B: Treatment level progress and time spent in treatment in the prediction of outcomes following drug-free therapeutic community treatment. Addiction 1998; 93: 1051-1064. (Pubitemid 28320997)
20. Chalmers I, Altman D (eds): Systematic Reviews. London, BMJ Publishing Group, 1995.
21. Denis C, Menguy V, Notz N, Auriacombe M: Rôle de l'expertise scientifique sur les drogues et les dépendances: L'exemple de la collaboration Cochrane. Rev Toxibase 2004; 11: 1-10.
22. Fernandez-Montalvo J, Lopez-Goni JJ, Illescas C, Landa N, Lorea I: Evaluation of a therapeutic community treatment program: A long-term follow-up study in Spain. Subst Use Misuse 2008; 43: 1362-1377.
23. Greenwood GL, Woods WJ, Guydish J, Bein E: Relapse outcomes in a randomized trial of residential and day drug abuse treatment. J Subst Abuse Treat 2001; 20: 15-23. (Pubitemid 32178177)
24. Guydish J, Sorensen JL, Chan M, Werdegar D, Bostrom A, Acampora A: A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes. J Consult Clin Psychol 1999; 67: 428-434. (Pubitemid 29266513)
25. Johnson K, Pan Z, Young L, Vanderhoff J, Shamblen S, Browne T, Linfield K, Suresh G: Therapeutic community drug treatment success in Peru: A follow-up outcome study. Subst Abuse Treat Prev Policy 2008; 3: 26.
26. Liberty HJ, Johnson BD, Jainchill N, Ryder J, Messina M, Reynolds S, Hossain M: Dynamic recovery: Comparative study of therapeutic communities in homeless shelters for men. J Subst Abuse Treat 1998; 15: 401-423. (Pubitemid 28409322)
27. McCusker J, Bigelow C, Vickers-Lahti M, Spotts D, Garfield F, Frost R: Planned duration of residential drug abuse treatment: Efficacy versus effectiveness. Addiction 1997; 92: 1467-1478. (Pubitemid 27499559)
28. McCusker J, Stoddard A, Frost R, Zorn M: Planned versus actual duration of drug abuse treatment. Reconciling observational and experimental evidence. J Nerv Ment Dis 1996; 184: 482-489. (Pubitemid 26285728)
29. Messina N, Wish E, Nemes S: Predictors of treatment outcomes in men and women admitted to a therapeutic community. Am J Drug Alcohol Abuse 2000; 26: 207-227. (Pubitemid 30366626)
30. Messina NP, Wish ED, Nemes S: Therapeutic community treatment for substance abusers with antisocial personality disorder. J Subst Abuse Treat 1999; 17: 121-128. (Pubitemid 29354130)
31. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD: A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 1999; 56: 507-514. (Pubitemid 29304643)
32. Crits-Cristoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken L, Muenz L, Thase M, Weiss R, Gastfriend D, Woody G, Barber J, Butler S, Daley D, Salloum I, Bishop S, Najavits L, Lis J, Mercer D, Griffin M, Moras K, Beck A: Psychosocial treatments for cocaine dependence. Arch Gen Psychiatry 1999; 56: 493-502.
33. Mangrum L: Psychosocial treatments for cocaine dependence. Addict Behav 2009; 34: 898-904.
34. Condelli WS, Koch MA, Fletcher B: Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus: The New Jersey Substance Abuse Treatment Campus, Seacaucus, NJ. J Subst Abuse Treat 2000; 18: 395-407. (Pubitemid 30254364)
35. Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A: Drug abuse day treatment: A randomized clinical trial comparing day and residential treatment programs. J Consult Clin Psychol 1998; 66: 280-289. (Pubitemid 28208310)
36. McCusker J, Vickers-Lahti M, Stoddard A, Hindin R, Bigelow C, Zorn M, Garfield F, Frost R, Love C, Lewis B: The effectiveness of alternative planned durations of residential drug abuse treatment. Am J Public Health 1995; 85: 1426-1429.
37. Nuttbrock LA, Rahav M, Rivera JJ, Ng-Mak DS, Link BG: Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatr Serv 1998; 49: 68-76. (Pubitemid 28049060)
38. Sacks S, Sacks JY, McKendrick K, Banks S, Stommel J: Modified TC for MICA offenders: Crime outcomes. Behav Sci Law 2004; 22: 477-501. (Pubitemid 39070984)
39. Wexler HK: The amity prison TC evaluation. Criminal Justice Behav 1999; 26: 147-167.
40. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S: Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2008;CD005031.
41. Srisurapanont M, Jarusuraisin N: Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2005;CD001867.